Estats Units - anglès - NLM (National Library of Medicine)

covis pharmaceuticals inc - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 100 ug in 1 ml - lanoxin is indicated for the treatment of mild to moderate heart failure. lanoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, lanoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these 3 drugs cannot be specified. lanoxin is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation. digitalis glycosides are contraindicated in patients with ventricular fibrillation or in patients with a known hypersensitivity to digoxin. a hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin.

Estats Units - anglès - NLM (National Library of Medicine)

mylan institutional inc. - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 0.125 mg - digitek ® (digoxin tablets) is indicated for the treatment of mild to moderate heart failure in adults. digitek ® (digoxin tablets) increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digitek ® (digoxin tablets) should be used in combination with a diuretic and an angiotensin-converting enzyme (ace) inhibitor. digitek ® (digoxin tablets) increases myocardial contractility in pediatric patients with heart failure. digitek ® (digoxin tablets) is indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation. digitek ® (digoxin tablets) is contraindicated in patients with: - ventricular fibrillation

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - digoxin - oral tablet - 62.5microgram

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - digoxin - oral tablet - 125microgram

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - digoxin - oral tablet - 250microgram

Panamà - anglès - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

kern pharma s.l. - digoxina - digoxina....0.25 mg

Panamà - anglès - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios pisa, s.a. de c.v. - digoxina - digoxina....500 ug

Panamà - anglès - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

empresa laboratorios aica - digoxina - digoxina....0.5 mg

Panamà - anglès - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios vijosa s.a. de c.v. - digoxina - digoxina....0,25 mg

Israel - anglès - Ministry of Health

padagis israel agencies ltd, israel - digoxin - elixir - digoxin 0.05 mg / 1 ml - digoxin - digoxin - lanoxin is indicated whenever digitalis therapy is required for the treatment of congestive heart failure, atrial fibrilation and/or flutter and supra-ventricular tachycardia.